In the fall of 2020, even as scientists raced to develop Covid-19 vaccines, Americans’ trust in these lifesaving shots plummeted. Many became more skeptical because of the behavior of U.S. leaders. Our recent study, published in the Journal of Health Politics, Policy and Law, tracks how the Trump administration applied public pressure on the FDA during the 2020 election season, sparking a crisis of vaccine confidence.
On Aug. 23, 2020, for example, then-FDA Commissioner Stephen Hahn stood beside President Trump to announce the emergency authorization of convalescent plasma for Covid-19 treatment — and wildly overstated the efficacy of the intervention. That marked the first time in FDA history that a president personally participated in announcing a treatment authorization.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.